Tracking the longitudinal course of physiologic and mental health functioning among individuals in substance use disorder treatment - Report - MDSpire

Tracking the longitudinal course of physiologic and mental health functioning among individuals in substance use disorder treatment

  • By

  • Wendy Insalaco

  • Charlotte Clapham

  • Brett Gelino

  • Jami Mayo Barney

  • Brianna Billings

  • Jennifer D. Ellis

  • J. Gregory Hobelmann

  • Andrew S. Huhn

  • Vadim Zipunnikov

  • Jill A. Rabinowitz

  • June 10, 2026

  • 0 min

Share

Longitudinal Analysis of Physiological and Mental Health Changes in SUD Treatment

Overview

This study examines the relationship between physiological indicators and self-reported mental health in individuals undergoing treatment for substance use disorders (SUD). Notable findings include significant associations between changes in resting heart rate (RHR) and heart rate variability (HRV) with improvements in stress, anxiety, and depressive symptoms during the first month of treatment.

Background

Incorporate specific references to studies that quantify treatment dropout rates and overdose risks.

Data Highlights

Physiological MeasureImprovement in Mental Health SymptomsPercentage of Participants
Decreased RHRDecreased Stress39%
Decreased RHRDecreased Anxiety42%
Decreased RHRImproved Depressive Symptoms39%
Increased HRVDecreased Stress39%
Increased HRVImproved Anxiety39%
Increased HRVReduced Depressive Symptoms41%

Key Findings

  • 39% of participants with decreased RHR reported decreased stress.
  • 42% of participants with decreased RHR reported decreased anxiety.
  • 39% of participants with decreased RHR reported improved depressive symptoms.
  • 39% of participants with increased HRV reported decreased stress.
  • 41% of participants with increased HRV reported reduced depressive symptoms.
  • Changes in physiological metrics varied significantly among individuals during the first month of treatment.

Clinical Implications

Integrating physiological measures such as RHR and HRV with self-reported mental health assessments can provide a more comprehensive understanding of patient progress in SUD treatment. This approach may help clinicians tailor interventions to individual needs, potentially improving treatment outcomes.

Conclusion

The study underscores the importance of monitoring both physiological and mental health indicators in individuals undergoing SUD treatment. Such integrated assessments can facilitate timely interventions and enhance recovery efforts.

Related Resources & Content

  1. BMC Psychiatry (Springer), 2023 -- Longitudinal Analysis of Recovery Domains in Patients with Schizophrenia Spectrum Disorders: Findings from a Six-Year Follow-Up Study.
  2. Open Forum Infectious Diseases -- Investigating the Relationships Among Polysubstance Use, Social Determinants of Health, and Mental Health Symptoms in Individuals Living with HIV.
  3. BMC Psychiatry (Springer), 2023 -- The Influence of Childhood Abuse on Early Substance Use: Gender Variations in the Effects of Different Maltreatment Types and Associated Psychiatric Disorders.
  4. Management of Substance Use Disorder (SUD) (2021) - VA/DOD Clinical Practice Guidelines.
  5. Final Recommendation Statement: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce.
  6. BMC Psychiatry (Springer) — Skin Conditions in Hospitalized Patients with Substance Use Disorders: A Comparative Analysis of Alcohol and Drug Users
  7. Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders | SAMHSA.
  8. Using SAMHSA Funds to Implement Evidence-Based Contingency Management Services.
  9. Final Recommendation Statement: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
  10. Management of Substance Use Disorder (SUD) (2021) - VA/DOD Clinical Practice Guidelines
  11. Heart rate variability in mental disorders: an umbrella review of meta-analyses | Translational Psychiatry
  12. Changes in heart rate variability in patients of alcohol dependence syndrome-Do we have a biomarker for craving? - PubMed
  13. Heart Rate Variability Biofeedback for Substance Use Disorder: A Randomized Clinical Trial | Trials | JAMA Psychiatry | JAMA Network
  14. Sleep alterations in substance use disorders: a systematic review and meta-analysis - ScienceDirect
  15. Are Wearable Photoplethysmogram-Based Heart Rate Variability Measures Equivalent to Electrocardiogram? A Simulation Study - PubMed
  16. Early implementation of an electronic measurement-based care tool in substance use disorder treatment clinics - PubMed
  17. Measurement-Based Care – Standardized Tools and Instruments | Joint Commission

Original Source(s)

Related Content